Howard Minott
Urology · Ravenna, OHNPI 1780650697
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.1% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Astellas Pharma US Inc at 30.6% of the total. Reporting peaked in 2021 at $736 and has fallen 97.1% since, to $21 in 2024. That places this record below the midpoint for urology clinicians in OH, where the typical reported total is $2,547.
Across 135 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$804
- AbbVie$322
- Axonics, Inc.$320
- Boston Scientific$118
- Neotract Inc.$117
- Convatec Inc.$99
- plus $851 from 19 others
What the payments were for
- Food & beverage$2,39791%
- Education$2359%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 42 | $804 |
| AbbVie(2 entities) | 18 | $322 |
| Axonics, Inc. | 14 | $320 |
| Boston Scientific | 7 | $118 |
| Neotract Inc. | 5 | $117 |
| Convatec Inc. | 6 | $99 |
| Antares Pharma, Inc. | 5 | $91 |
| Pfizer | 1 | $86 |
| Teleflex LLC | 4 | $70 |
| Urovant Sciences Inc | 4 | $68 |
| Clarus Therapeutics Inc. | 4 | $68 |
| Myovant Sciences Inc. | 5 | $67 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $63 |
| Endo Pharmaceuticals Inc. | 4 | $58 |
| Medtronic | 3 | $38 |
| Halozyme Inc | 2 | $33 |
| Hollister Incorporated | 1 | $32 |
| Rochester Medical Corporation | 1 | $32 |
| AstraZeneca | 2 | $28 |
| 180 Medical, Inc. | 1 | $28 |
| ABC Home Medical Supply, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Bayer | 1 | $17 |
| Coloplast | 1 | $15 |
| Johnson & Johnson | 1 | $12 |
How this compares
$2,631 in reported general payments places this provider in the 50th percentile of 485 urology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 24 | $420 |
| Finasteride | 20 | $74 |
Paid to pharmacies, not to this prescriber.
Other urology in Ravenna
- Lawrence GervasiMiddleburg Heights$1.1M
- Howard GoldmanCleveland$721K
- Ronney AbazaWorthington$374K
- Sriharan SivalingamCleveland$276K
- Sandip VasavadaCleveland$263K
- Jihad KaoukCleveland$234K
- Benjamin MartinGahanna$205K
- Ruben OlivaresCleveland$184K
- Abhinav SidanaCincinnati$174K
- Raymond RackleyCleveland$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.